Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Appleton, Ryan
DECREASE, NCT04319783: Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA	Recruiting	2	87	RoW	Darolutamide, NUBEQA, Bayer HealthCare Pharmaceuticals Inc., Radiotherapy	Trans Tasman Radiation Oncology Group, Bayer, Peter MacCallum Cancer Centre, Australia	Advanced Prostate Carcinoma, Cancer of Prostate, PSA, Castrate Resistant Prostate Cancer	06/26	06/26
RADICALPC, NCT03127631: A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients	Recruiting	N/A	6000	Canada, US, RoW	Nutrition, Exercise, Smoking cessation, Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin), ACE inhibitor	McMaster University, Prostate Cancer Canada, Canadian Cancer Society (CCS)	Prostate Cancer, Cardiovascular Disease	12/25	12/25